{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:24:48Z","timestamp":1789050288517,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.nbd.2021.105443","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:29:56Z","timestamp":1625790596000},"page":"105443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Targeted overexpression of glutamate transporter-1 reduces seizures and attenuates pathological changes in a mouse model of epilepsy"],"prefix":"10.1016","volume":"157","author":[{"given":"Allison R.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Cullion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema K.","family":"Tiwari-Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest V.","family":"Pedapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin K.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105443_bb0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.wneu.2016.12.074","article-title":"Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States","volume":"99","author":"Asadi-Pooya","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.nbd.2021.105443_bb0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5698\/1535-7597.18.3.172","article-title":"Astrocytes: stars of the sacred disease","volume":"18","author":"Binder","year":"2018","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.nbd.2021.105443_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.seizure.2008.11.006","article-title":"The impact of side effects on long-term retention in three new antiepileptic drugs","volume":"18","author":"Bootsma","year":"2009","journal-title":"Seizure."},{"key":"10.1016\/j.nbd.2021.105443_bb0025","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s12035-013-8598-0","article-title":"Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson\u2019s model","volume":"49","author":"Chotibut","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105443_bb0030","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.27077","article-title":"Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson\u2019s disease model","volume":"32","author":"Chotibut","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105443_bb0035","doi-asserted-by":"crossref","first-page":"113196","DOI":"10.1016\/j.expneurol.2020.113196","article-title":"Ultrastructural and functional changes at the tripartite synapse during epileptogenesis in a model of temporal lobe epilepsy","volume":"326","author":"Clarkson","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajhg.2016.06.003","article-title":"De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies","volume":"99","author":"Consortium, E. K","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2021.105443_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105443_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(03)15166-5","article-title":"Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy","volume":"363","author":"Eid","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2021.105443_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.omtm.2018.03.001","article-title":"Seizure-suppressant and neuroprotective effects of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy","volume":"9","author":"Falcicchia","year":"2018","journal-title":"Mol Ther. Methods Clin. Dev."},{"key":"10.1016\/j.nbd.2021.105443_bb0060","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/acschemneuro.9b00061","article-title":"Novel positive allosteric modulators of glutamate transport have neuroprotective properties in an in vitro excitotoxic model","volume":"10","author":"Falcucci","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2021.105443_bb0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/glia.22936","article-title":"GLT1 overexpression reverses established neuropathic pain-related behavior and attenuates chronic dorsal horn neuron activation following cervical spinal cord injury","volume":"64","author":"Falnikar","year":"2016","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2021.105443_bb0070","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awh555","article-title":"Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation","volume":"128","author":"Fedele","year":"2005","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2021.105443_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2021.105443_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2008.08.043","article-title":"A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)","volume":"157","author":"Furness","year":"2008","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2021.105443_bb0085","doi-asserted-by":"crossref","first-page":"19177","DOI":"10.1074\/jbc.M112.355909","article-title":"Protein kinase C (PKC)-promoted endocytosis of glutamate transporter GLT-1 requires ubiquitin ligase Nedd4-2-dependent ubiquitination but not phosphorylation","volume":"287","author":"Garcia-Tardon","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2021.105443_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2021.01.004","article-title":"Effects of ceftriaxone on ethanol drinking and GLT-1 expression in ethanol dependence and relapse drinking","volume":"92","author":"Griffin","year":"2021","journal-title":"Alcohol."},{"key":"10.1016\/j.nbd.2021.105443_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022135","article-title":"Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke","volume":"6","author":"Harvey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105443_bb0100","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1093\/cercor\/bhy196","article-title":"Ca2+ signals in astrocytes facilitate spread of epileptiform activity","volume":"28","author":"Heuser","year":"2018","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2021.105443_bb0105","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1460-9568.2000.00104.x","article-title":"Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances","volume":"12","author":"Hinterkeuser","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105443_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105443_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.expneurol.2016.05.003","article-title":"Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy","volume":"283","author":"Hubbard","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14581\/jer.16002","article-title":"Beta lactams antibiotic ceftriaxone modulates seizures, oxidative stress and connexin 43 expression in hippocampus of pentylenetetrazole kindled rats","volume":"6","author":"Hussein","year":"2016","journal-title":"J. Epilepsy. Res."},{"key":"10.1016\/j.nbd.2021.105443_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/brain\/awl317","article-title":"TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis","volume":"130","author":"Ivens","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2021.105443_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nbd.2012.03.032","article-title":"Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus","volume":"47","author":"Kong","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105443_bb0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2012.02.002","article-title":"Decreased expression of the glial water channel aquaporin-4 in the intrahippocampal kainic acid model of epileptogenesis","volume":"235","author":"Lee","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4103\/1673-5374.155434","article-title":"Short-term use of antiepileptic drugs is neurotoxic to the immature brain","volume":"10","author":"Liu","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.nbd.2021.105443_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12868-020-00606-z","article-title":"Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice","volume":"22","author":"Luo","year":"2021","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2021.105443_bb0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0306-4522(94)00613-A","article-title":"Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield","volume":"66","author":"Magloczky","year":"1995","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2021.105443_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.52.3.453","article-title":"Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy","volume":"52","author":"Mathern","year":"1999","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2021.105443_bb0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pbb.2014.03.011","article-title":"Ceftriaxone, a GLT-1 transporter activator, disrupts hippocampal learning in rats","volume":"122","author":"Matos-Ocasio","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2021.105443_bb0165","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbadis.2016.03.008","article-title":"Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease","volume":"1862","author":"Munoz-Ballester","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2021.105443_bb0170","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1113\/jphysiol.2009.177881","article-title":"Up-regulation of GLT-1 severely impairs LTD at mossy fibre--CA3 synapses","volume":"587","author":"Omrani","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2021.105443_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3988\/jcn.2008.4.3.99","article-title":"Cognitive effects of antiepileptic drugs","volume":"4","author":"Park","year":"2008","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0180","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/glia.23956","article-title":"Endocytosis of the glutamate transporter 1 is regulated by laforin and Malin: implications in Lafora disease","volume":"69","author":"Perez-Jimenez","year":"2021","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2021.105443_bb0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnmol.2019.00164","article-title":"Post-translational regulation of GLT-1 in neurological diseases and its potential as an effective therapeutic target","volume":"12","author":"Peterson","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2021.105443_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroscience.2019.05.048","article-title":"Regulation of synaptosomal GLT-1 and GLAST during epileptogenesis","volume":"411","author":"Peterson","year":"2019","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2021.105443_bb0195","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3389\/fneur.2020.01006","article-title":"Astrocyte glutamate uptake and signaling as novel targets for antiepileptogenic therapy","volume":"11","author":"Peterson","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0200","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1523\/JNEUROSCI.4255-14.2015","article-title":"Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes","volume":"35","author":"Petr","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105443_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2021.105443_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246068","article-title":"Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy","volume":"16","author":"Ramandi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105443_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2021.105443_bb0220","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0337-20.2021","article-title":"The kainic acid models of temporal lobe epilepsy","volume":"8","author":"Rusina","year":"2021","journal-title":"eNeuro."},{"key":"10.1016\/j.nbd.2021.105443_bb0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1423-0127-17-62","article-title":"Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6\/2 model of Huntington\u2019s disease","volume":"17","author":"Sari","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.nbd.2021.105443_bb0230","series-title":"The Neurobiology of Disease","first-page":"349","article-title":"Temporal lobe epilepsy","author":"Scharfman","year":"2007"},{"key":"10.1016\/j.nbd.2021.105443_bb0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cne.23450","article-title":"Laminar and subcellular heterogeneity of GLAST and GLT-1 immunoreactivity in the developing postnatal mouse hippocampus","volume":"522","author":"Schreiner","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2021.105443_bb0240","series-title":"The Journal of Experimental Medicine","first-page":"547","article-title":"Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy","volume":"Vol. 214","author":"Sha","year":"2016"},{"key":"10.1016\/j.nbd.2021.105443_bb0245","series-title":"Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1","first-page":"1699","volume":"276","author":"Tanaka","year":"1997"},{"key":"10.1016\/j.nbd.2021.105443_bb0250","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0306-4522(98)00301-7","article-title":"Expression of the glutamate transporters in human temporal lobe epilepsy","volume":"88","author":"Tessler","year":"1999","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2021.105443_bb0255","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/nan.12150","article-title":"Review: hippocampal sclerosis in epilepsy: a neuropathology review","volume":"40","author":"Thom","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105443_bb0260","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/gt.2014.82","article-title":"Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy","volume":"21","author":"Young","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2021.105443_bb0265","doi-asserted-by":"crossref","first-page":"821","DOI":"10.15585\/mmwr.mm6631a1","article-title":"National and state estimates of the numbers of adults and children with active epilepsy - United States, 2015","volume":"66","author":"Zack","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.nbd.2021.105443_bb0270","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0158-18.2018","article-title":"Targeting the mouse ventral Hippocampus in the intrahippocampal kainic acid model of temporal lobe epilepsy","volume":"5","author":"Zeidler","year":"2018","journal-title":"eNeuro."},{"key":"10.1016\/j.nbd.2021.105443_bb0275","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.nbd.2009.12.020","article-title":"Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of tuberous sclerosis complex","volume":"37","author":"Zeng","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105443_bb0280","doi-asserted-by":"crossref","first-page":"e2574","DOI":"10.1038\/cddis.2016.454","article-title":"Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson\u2019s disease model","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:27:07Z","timestamp":1760851627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":56,"alternative-id":["S0969996121001923"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105443","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted overexpression of glutamate transporter-1 reduces seizures and attenuates pathological changes in a mouse model of epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105443"}}